08:00 , Jan 14, 2002 |  BC Week In Review  |  Company News

Renovis board of directors update

Renovis Inc., South San Francisco, Calif.   Business: Neurological   Appointed: Nancy Crowell, founding partner of Applied Genomic Technology Capital Funds  ...
08:00 , Jan 9, 2002 |  BC Extra  |  Financial News

Renovis raises $34.3 million

Renovis (South San Francisco, Calif.) raised $34.3 million in venture financing. Investors included HBM BioVentures; Applied Genomic Technology Capital Funds; Bioveda Capital; De Novo Ventures; International BM Biomedicine Holdings; Vertex Management & Double Helix ;...
07:00 , Sep 24, 2001 |  BC Week In Review  |  Company News

Morphotek board of directors update

Morphotek Inc., Philadelphia, Penn.   Business: Genomics   Appointed: John Kim, managing director of Burrill & Co.; Enrico Petrillo, general partner at CB Health Ventures LLC; and David Stone, founding partner of Applied Genomic Technology...
07:00 , Aug 13, 2001 |  BC Extra  |  Financial News

Morphotek raises $10 million

Directed evolution play Morphotek (Philadelphia, Penn.) raised $10 million in a second round of private financing. Investors included Applied Genomic Technology Capital Funds; Burrill & Co.; CB Healthcare Ventures; Tonbridge Capital; Trieste Investment Group; and...
08:00 , Mar 5, 2001 |  BC Extra  |  Financial News

$150 million closing for genomics fund

Applied Genomic Technology Capital Funds (ATGC Funds) has raised a $150 million venture fund, which is focused on early-stage genomics companies. ATGC Funds was founded by NewcoGen Group and OneLiberty Ventures....
08:00 , Jan 2, 2001 |  BioCentury  |  Finance

2001 Financial Markets Preview: Job 1: Keep the investors

Investors tend to focus on stock prices to measure the health of companies and the market in general. But volume also is important because of its effect on the ability of investors to get in...
08:00 , Jan 2, 2001 |  BioCentury  |  Finance

Ebb & Flow

Prudential's plans to overhaul its securities unit, which include a major reduction in its investment banking presence, has left the future of Prudential Vector Securities up in the air. Pru acquired Vector in 1999 to...
07:00 , Oct 2, 2000 |  BC Week In Review  |  Company News

Cell Genesys board of directors update

Cell Genesys Inc. (CEGE), Foster City, Calif.   Business: Cancer, Gene/Cell therapy, Infectious diseases   Appointed: Nancy Crowell, founding partner at Applied Genomic Technology Capital Funds  ...
07:00 , Oct 2, 2000 |  BioCentury  |  Finance

3Q Financial Markets Review: Happy Birthday

The IPO window that opened exactly one year ago has given birth to many publicly held companies that are promising to provide value from the genetic code, as well as more traditional product-oriented companies. In...
07:00 , Oct 2, 2000 |  BioCentury  |  Finance

Bio-equity sizzles

All was well in biotech last week, even as the tech-heavy NASDAQ Composite shed 3 percent. The BioCentury 100 traded up 2 percent, while $856.3 million was raised in six underwritten deals that included a...